Potassium Iodide KI
Recent terrorist events have many people concerned about potential future attacks using radioactive materials. Taking potassium iodide (KI) tablets after an incident involving radioactive materials may or may not limit the risk of damage to a person’s thyroid gland from ionizing radiation. The Centers for Disease Control and Prevention (CDC) has prepared this fact sheet to further explain when KI might be appropriate and what people should consider before making a decision to take KI.
Local emergency management officials will tell people when to take KI. If a nuclear incident occurs, officials will have to find out which radioactive substances are present before recommending that people take KI. If radioactive iodine is not present, then taking KI will not protect people. If radioactive iodine is present, then taking KI will help protect a person’s thyroid gland from the radioactive iodine. Taking KI will not protect people from other radioactive substances that may be present along with the radioactive iodine.
KI comes in tablets of 130 mg. A one-time dose at the levels recommended in this fact sheet is usually all that is required. However, if a person expects to be exposed to radioactive iodine for more than 24 hours, another dose should be taken every 24 hours. People should listen to emergency management officials for recommendations after an incident. According to the FDA,
- Adults should take one 130-mg tablet.
- Children between 3 and 18 years of age should take one-half of a 130-mg tablet (65 mg).
- Children between 1 month and 3 years of age should take one-fourth of a 130-mg tablet (32 mg).
- Infants from birth to 1 month of age should be given one-eighth of a 130-mg tablet (16 mg).
- Women who are breastfeeding should take the adult dose, and their infants should receive the recommended infant dose.
- Children who are approaching adult size (greater than or equal to 150 pounds) should take the adult dose regardless of their age.
KI is a salt of iodine. It is one of several ingredients that can be added to table salt to make it iodized. KI has also been approved by the FDA as a nonprescription drug for use as a “blocking agent” to prevent the human thyroid gland from absorbing radioactive iodine. However, KI may not provide people with 100% protection against all radioactive iodine. Its effectiveness will depend on a variety of factors, including when a person takes it, how much iodine is already in the person’s thyroid, how fast the person’s body processes it, and the amount of radioactive iodine the person is exposed to. Iodized table salt will not provide enough iodine to protect the thyroid and should not be used as a substitute.Why KI would be important in the event of a nuclear incident
Because the thyroid will rapidly absorb any iodine that is in the body, people may need to take KI tablets soon after an incident that involves radioactive iodine. The KI will saturate the thyroid gland with iodine and help prevent it from absorbing radioactive iodine. However, KI does not prevent the effects of other radioactive elements. Using KI will only protect the thyroid gland from radioactive iodine. It will not protect other parts of the body from radioactive iodine, and it will not protect a person from other radioactive materials that may be released.
Who should or should not take KI when the public is told to do so
Children are the most susceptible to the dangerous effects of radioactive iodine. The FDA and the World Health Organization (WHO) recommend that children from newborn to 18 years of age all take KI unless they have a known allergy to iodine.
Women who are breastfeeding should also take KI, according to the FDA and WHO, to protect both themselves and their breast milk. However, breastfeeding infants should still be given the recommended dosage of KI to protect them from any radioactive iodine that they may breathe in or drink in breast milk.
Young adults between the ages of 18 and 40 have a smaller chance of developing thyroid cancer or thyroid disease from exposure to radioactive iodine than do children. However, the FDA and WHO still recommend that people ages 18 to 40 take the recommended dose of KI. This includes pregnant and breast-feeding women, who should take the same dose as other young adults.
Adults over the age of 40 have the smallest chance of developing thyroid cancer or thyroid disease after an exposure to radioactive iodine, but they have a greater chance of having an allergic reaction to the high dose of iodine in KI. Because of this, they are not recommended to take KI unless a very large dose of radioactive iodine is expected. People should listen to emergency management officials for recommendations after an incident.
Medical conditions that make it dangerous to take KI
The high concentration of iodine in KI can be harmful to some people. People should not take KI if they:
- have ever had thyroid disease (such as hyperthyroidism, thyroid nodules, or goiter).
- know they are allergic to iodine (as in x-ray dye or shellfish).
- have certain skin disorders (such as dermatitis herpetiformis or urticaria vasculitis).












